| |
Matthew A. Gibbs
General Partner
Boston, MA
mgibbs@oxbio.com |
Mr. Gibbs joined Oxford Bioscience Partners in 1997. He has 15 years of investing experience in the lifescience and technology venture industry. Mr. Gibbs leads the bio-energy initiative at Oxford with investments in Luca Technologies, microbial generated natural gas from coal and Glori Oil, biotechnology enhanced oil recovery.
Current and past investments include Zettacore, molecular memory for the electronics industry; Stratagene, lifescience instruments and reagents acquired by Agilent for $250M; Biosource, lifescience reagents acquired by Invitrogen for $130M and Zone Labs, intrusion detection security software acquired by Checkpoint for $290M.
Prior to joining Oxford, Mr. Gibbs was with the Venture Fund of Washington a healthcare venture capital firm. Previously, he was with MedVest, Inc a venture capital syndicated fund with Johnson & Johnson Development Corp, Oak Investment Professionals and Marquette Venture Partners. Mr. Gibbs received his B.A. from the University of Colorado and completed Executive Programs at Harvard Business School.
Mr. Gibbs lives in Boston with his wife and twin daughters.
Back to OBP Team
|
|